Dashboard
Manage Tickers

CYCCCyclacel Pharmaceuticals, Inc.

Nasdaq cyclacel.com


$ 1.26 $ 0.00 (0 %)    

Tuesday, 20-Aug-2024 15:58:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 1.22
$ 1.23
$ 1.22 x 350
$ 1.27 x 250
$ 1.23 - $ 1.26
$ 1.21 - $ 11.34
31,811
na
2.41M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-29-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-08-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-12-2020 03-31-2020 10-Q
19 03-05-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-28-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-30-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-13-2016 03-31-2016 10-Q
35 03-29-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cyclacel-receives-grant-of-european-patent-ep4013503-titled-crystalline-forms-of-pyrimidino-diazepine-derivative-for-the-treatment-of-tumors
Cyclacel Receives Grant Of European Patent...
08/15/2024 16:03:12

cyclacel-pharmaceuticals-q2-2024-gaap-eps-072-beats-144-estimate-sales-400k-miss-3000k-estimate
Cyclacel Pharmaceuticals Q2 2024 GAAP EPS ...
08/14/2024 20:20:53

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate...

Core News & Articles
Cyclacel Pharmaceuticals to Receive Europe...
06/26/2024 13:19:32

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 12:06:20

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/06/2024 20:31:11

Core News & Articles
Cyclacel's Fadraciclib Reports Efficacy In...
06/04/2024 12:27:03

 - Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action -BERKELEY HEIGH...

Core News & Articles
Cyclacel Pharmaceuticals To Present Clinic...
06/03/2024 12:38:57

- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study i...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/24/2024 20:31:11

cyclacel-pharmaceuticals-q1-eps-227-beats-474-estimate-sales-2900k
Cyclacel Pharmaceuticals Q1 EPS $(2.27) Be...
05/14/2024 20:24:00

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate...

why-akoustis-technologies-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Akoustis Technologies Shares Are Tradi...
05/13/2024 17:01:38

why-janone-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket
Why JanOne Shares Are Trading Higher By 19...
05/13/2024 09:46:10

roth-mkm-maintains-buy-on-cyclacel-pharmaceuticals-lowers-price-target-to-11
Roth MKM Maintains Buy on Cyclacel Pharmac...
05/03/2024 14:13:52

Roth MKM analyst Jonathan Aschoff maintains Cyclacel Pharmaceuticals (NASDAQ:CYCC) with a Buy and lowers the price target fr...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 16:31:13

why-pinterest-shares-are-trading-higher-by-17-here-are-20-stocks-moving-premarket
Why Pinterest Shares Are Trading Higher By...
05/01/2024 12:19:33

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 12:06:50

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

why-he-equipment-services-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why H&E Equipment Services Shares Are Trad...
04/30/2024 17:24:09

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

Core News & Articles
Market-Moving News for April 30th
04/30/2024 12:45:17

MMM: 8.3% | 3M shares are trading higher following a Q1 earnings beat, reversing after initially falling. CYCC: 103% | Cyclace...

why-genedx-shares-are-trading-higher-by-37-here-are-20-stocks-moving-premarket
Why GeneDx Shares Are Trading Higher By 37...
04/30/2024 12:08:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION